BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2133845)

  • 1. Current issues in clinical and experimental cardiac transplantation.
    Disesa VJ
    J Card Surg; 1990 Sep; 5(3):204-9. PubMed ID: 2133845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic mechanisms of cardiac transplant rejection.
    Duquesnoy RJ; Cramer DV
    Cardiovasc Clin; 1990; 20(2):87-103. PubMed ID: 2404607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic sensitization in recipients of left ventricular assist devices.
    John R; Lietz K; Schuster M; Naka Y; Rao V; Mancini DM; Rose EA; Smith CR; Oz MC; Edwards NM; Itescu S
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):578-91. PubMed ID: 12658200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of histocompatibility on graft rejection and graft survival within a single center population of heart transplant recipients.
    Sheldon S; Yonan NA; Aziz TN; Hasleton PS; Rahman AN; Deiraniya AK; Campbell CS; Dyer PA
    Transplantation; 1999 Aug; 68(4):515-9. PubMed ID: 10480409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship among donor-recipient HLA mismatches, rejection, and death from coronary artery disease in cardiac transplant recipients.
    Kerman RH; Kimball P; Scheinen S; Radovancevic B; Van Buren CT; Kahan BD; Frazier OH
    Transplantation; 1994 Mar; 57(6):884-8. PubMed ID: 8154036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
    Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J
    Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac allograft vasculopathy: relationship with acute cellular rejection and histocompatibility.
    Costanzo-Nordin MR
    J Heart Lung Transplant; 1992; 11(3 Pt 2):S90-103. PubMed ID: 1623009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes in recipients of combined heart-kidney transplantation: multiorgan, same-donor transplant study of the International Society of Heart and Lung Transplantation/United Network for Organ Sharing Scientific Registry.
    Narula J; Bennett LE; DiSalvo T; Hosenpud JD; Semigran MJ; Dec GW
    Transplantation; 1997 Mar; 63(6):861-7. PubMed ID: 9089227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covert presensitization to HLA antigens in parous heart and lung transplant recipients may predispose to early allograft rejection.
    Tait BD; Dandie WJ; Griffiths AP; Esmore DS; Snell GI; Bergin P; Williams TJ
    Transplant Proc; 1995 Jun; 27(3):2143-4. PubMed ID: 7792912
    [No Abstract]   [Full Text] [Related]  

  • 11. HLA-DR matching improves survival after heart transplantation: is it time to change allocation policies?
    Kaczmarek I; Deutsch MA; Rohrer ME; Beiras-Fernandez A; Groetzner J; Daebritz S; Schmoeckel M; Spannagl M; Meiser B; Reichart B
    J Heart Lung Transplant; 2006 Sep; 25(9):1057-62. PubMed ID: 16962466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease.
    Kerman RH; Susskind B; Kerman D; Lam M; Gerolami K; Williams J; Kalish R; Campbell M; Katz S; Van Buren CT; Frazier H; Radovancevic B; Fife S; Kahan B
    J Heart Lung Transplant; 1998 Aug; 17(8):789-94. PubMed ID: 9730428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degree of HLA mismatch as a predictor of death from allograft arteriopathy after heart transplant.
    Cocanougher B; Ballantyne CM; Pollack MS; Payton-Ross C; Lowry R; Kleiman NS; Farmer JA; Noon GP; Short HD; Young JB
    Transplant Proc; 1993 Feb; 25(1 Pt 1):233-6. PubMed ID: 8438282
    [No Abstract]   [Full Text] [Related]  

  • 14. Utility of post-transplant anti-HLA antibody measurements in pediatric cardiac transplant recipients.
    Xydas S; Yang JK; Burke EM; Chen JM; Addonizio LJ; Mital SR; Itescu S; Hsu DT; Lamour JM
    J Heart Lung Transplant; 2005 Sep; 24(9):1289-96. PubMed ID: 16143247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of HLA matching on graft survival and incidence and severity of graft rejection in cardiac transplantation.
    Suberbielle C; Dorent R; Vaissier E; Nataf P; Busson M; Cabrol A; Cabrol C; Charron D; Raffoux C; Gandjbakhch I
    Transplant Proc; 1994 Feb; 26(1):245-6. PubMed ID: 8108959
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic rejection in H-2 matched cardiac allografts: early emergence of vasculopathy, alloantibody, and accumulation of IFN-gamma and IL-10 mRNA.
    Zhang QW; Tomita Y; Matsuzaki G; Uchida T; Yoshikawa M; Nakashima Y; Sueishi K; Nomoto K; Yasui H
    Transpl Int; 2001 Jun; 14(3):143-52. PubMed ID: 11499903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor and antibodies to HLA and MICA antigens in heart transplant recipients.
    Pavlova YA; Malek I; Honsova E; Netuka I; Sochman J; Lodererova A; Kolesar L; Striz I; Skibova J; Slavcev A
    Tissue Antigens; 2010 Nov; 76(5):380-6. PubMed ID: 20604893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute antibody-mediated rejection of cardiac transplants.
    Reed EF; Demetris AJ; Hammond E; Itescu S; Kobashigawa JA; Reinsmoen NL; Rodriguez ER; Rose M; Stewart S; Suciu-Foca N; Zeevi A; Fishbein MC;
    J Heart Lung Transplant; 2006 Feb; 25(2):153-9. PubMed ID: 16446213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
    Lietz K; John R; Burke E; Schuster M; Rogers TB; Suciu-Foca N; Mancini D; Itescu S
    Circulation; 2005 Oct; 112(16):2468-76. PubMed ID: 16230499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunological algorithm to predict risk of high-grade rejection in cardiac transplant recipients.
    Itescu S; Tung TC; Burke EM; Weinberg AD; Mancini D; Michler RE; Suciu-Foca NM; Rose EA
    Lancet; 1998 Jul; 352(9124):263-70. PubMed ID: 9690405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.